2002. Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Medical Weekly. 132, 2930 (Jul. 2002), 414–414. DOI:https://doi.org/10.4414/smw.2002.10031.